InvestSMART

ReNerve Limited (ASX: RNV) - Announcements

Current share price for RNV : $0.087 0.002 (2.35%)+

ASX company news and announcements for ReNerve Limited (RNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ReNerve Limited (RNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ReNerve Limited (RNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ReNerve Limited (RNV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Positive 12-Month Data for NervAlign Nerve Guide Matrix 19 Oct 2026 9:20AM $0.077 $0.087 risen by 12.99%
$12 Positive FDA Feedback on NervAlign Nerve Guide Matrix 14 Oct 2026 9:28AM $0.080 $0.087 risen by 8.75%
$12 Change of Director's Interest Notice - P Savage 6 Oct 2026 1:34PM $0.080 $0.087 risen by 8.75%
$12 Change of Director's Interest Notice - M McGuire 6 Oct 2026 1:34PM $0.080 $0.087 risen by 8.75%
$12 Change of Director's Interest Notice - J Chick 6 Oct 2026 1:33PM $0.080 $0.087 risen by 8.75%
$12 Cleansing Notice 6 Oct 2026 1:18PM $0.080 $0.087 risen by 8.75%
$12 Application for quotation of securities - RNV 6 Oct 2026 1:14PM $0.080 $0.087 risen by 8.75%
$12 Proposed issue of securities - RNV 6 Oct 2026 9:53AM $0.080 $0.087 risen by 8.75%
$12 Notification regarding unquoted securities - RNV 6 Oct 2026 9:50AM $0.080 $0.087 risen by 8.75%
$12 Results of Meeting 5 Oct 2026 3:11PM $0.080 $0.087 risen by 8.75%
$12 ReNerve AGM Presentation 5 Oct 2026 1:20PM $0.080 $0.087 risen by 8.75%
$12 ReNerve completes first cases in Hong Kong and Malaysia 21 Sep 2026 9:08AM $0.074 $0.087 risen by 17.57%
$12 Change in substantial holding - J Chick 14 Sep 2026 10:35AM $0.074 $0.087 risen by 17.57%
$12 Change of Director's Interest Notice - J Chick 14 Sep 2026 10:19AM $0.074 $0.087 risen by 17.57%
$12 ReNerve and RMIT awarded $499k grant 7 Sep 2026 9:22AM $0.074 $0.087 risen by 17.57%
$12 Notice of Annual General Meeting/Proxy Form 3 Sep 2026 9:49AM $0.077 $0.087 risen by 12.99%
$12 ReNerve - Corporate Governance Statement 28 Aug 2026 9:42AM $0.073 $0.087 risen by 19.18%
$12 ReNerve - Appendix 4G 28 Aug 2026 9:41AM $0.073 $0.087 risen by 19.18%
$12 ReNerve - Full Year Results 28 Aug 2026 9:40AM $0.073 $0.087 risen by 19.18%
$12 ReNerve - 2026 Annual Report 28 Aug 2026 9:39AM $0.073 $0.087 risen by 19.18%
$12 ReNerve - Appendix 4E 28 Aug 2026 9:35AM $0.073 $0.087 risen by 19.18%
$12 Cleansing Notice 25 Aug 2026 12:59PM $0.077 $0.087 risen by 12.99%
$12 Application for quotation of securities - RNV 25 Aug 2026 12:54PM $0.077 $0.087 risen by 12.99%
$12 Proposed issue of securities - RNV 25 Aug 2026 9:09AM $0.077 $0.087 risen by 12.99%
$12 Quarterly Investor Presentation 19 Aug 2026 10:38AM $0.077 $0.087 risen by 12.99%

1 - 25 of 174 results

Page 1 of 7

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.